Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 801

1.

Chemoprevention of colorectal cancer.

Das D, Arber N, Jankowski JA.

Digestion. 2007;76(1):51-67. Epub 2007 Oct 19. Review.

PMID:
17947819
2.

Chemoprevention of colorectal cancer.

Gwyn K, Sinicrope FA.

Am J Gastroenterol. 2002 Jan;97(1):13-21. Review.

PMID:
11808936
3.

Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?

Gill S, Sinicrope FA.

Semin Oncol. 2005 Feb;32(1):24-34. Review.

PMID:
15726503
4.

Chemoprevention of colorectal cancer: feasibility in everyday practice?

Herszényi L, Farinati F, Miheller P, Tulassay Z.

Eur J Cancer Prev. 2008 Nov;17(6):502-14. doi: 10.1097/CEJ.0b013e3282f0c080. Review.

PMID:
18941372
5.

Review article: chemoprevention of colorectal cancer.

Courtney ED, Melville DM, Leicester RJ.

Aliment Pharmacol Ther. 2004 Jan 1;19(1):1-24. Review.

PMID:
14687163
6.

Chemoprevention of colorectal cancer: ready for routine use?

Arber N, Levin B.

Curr Top Med Chem. 2005;5(5):517-25. Review.

PMID:
15974946
7.

Use of NSAIDs for the chemoprevention of colorectal cancer.

Herendeen JM, Lindley C.

Ann Pharmacother. 2003 Nov;37(11):1664-74. Review.

PMID:
14565811
8.

Low dose aspirin, COX-inhibition and chemoprevention of colorectal cancer.

Benamouzig R, Uzzan B, Little J, Chaussade S.

Curr Top Med Chem. 2005;5(5):493-503. Review.

PMID:
15974944
9.

Colon cancer: preventive agents and the present status of chemoprevention.

Half E, Arber N.

Expert Opin Pharmacother. 2009 Feb;10(2):211-9. doi: 10.1517/14656560802560153 . Review.

PMID:
19236194
10.

Chemoprevention of colorectal cancer: systematic review and economic evaluation.

Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P.

Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Review.

11.
12.

Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention.

DuBois RN, Giardiello FM, Smalley WE.

Gastroenterol Clin North Am. 1996 Dec;25(4):773-91. Review.

PMID:
8960892
13.

Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer.

Jalving M, Koornstra JJ, De Jong S, De Vries EG, Kleibeuker JH.

Aliment Pharmacol Ther. 2005 Feb 15;21(4):321-39. Review.

14.

Combination chemoprevention: future direction of colorectal cancer prevention.

Zhou P, Cheng SW, Yang R, Wang B, Liu J.

Eur J Cancer Prev. 2012 May;21(3):231-40. doi: 10.1097/CEJ.0b013e32834dbbfd. Review.

PMID:
22456425
15.

Cyclooxygenase as a target for chemoprevention in colorectal cancer: lost cause or a concept coming of age?

Doherty GA, Murray FE.

Expert Opin Ther Targets. 2009 Feb;13(2):209-18. doi: 10.1517/14728220802653631 . Review.

PMID:
19236238
16.
17.

Recent advances in cancer chemoprevention, with emphasis on breast and colorectal cancer.

Decensi A, Costa A.

Eur J Cancer. 2000 Apr;36(6):694-709. Review.

PMID:
10762741
18.

Prospects in NSAID-derived chemoprevention of colorectal cancer.

Chell S, Patsos HA, Qualtrough D, H-Zadeh AM, Hicks DJ, Kaidi A, Witherden IR, Williams AC, Paraskeva C.

Biochem Soc Trans. 2005 Aug;33(Pt 4):667-71. Review.

PMID:
16042570
19.

Cyclo-oxygenase inhibition in colorectal adenomas and cancer.

Ricchi P, Pignata S, Iaffaioli RV, Daniele B.

J Clin Gastroenterol. 2003 Oct;37(4):281-7. Review.

PMID:
14506383
20.

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.

Thun MJ, Henley SJ, Patrono C.

J Natl Cancer Inst. 2002 Feb 20;94(4):252-66. Review.

PMID:
11854387

Supplemental Content

Support Center